Melody Harris - Jan 1, 2025 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role: Chf Ops Off, Pres, Informatics
Signature: /s/ Ali Olivo, Attorney-in-Fact
Stock symbol: NEO
Transactions as of: Jan 1, 2025
Transactions value $: $0
Form type: 4
Date filed: 1/3/2025, 04:11 PM
Previous filing: May 14, 2024
Next filing: Jan 16, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEO	Common Stock	Tax liability	$0	-7.07K	-6.43%	$0.00	103K	Jan 1, 2025	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NEO	Stock Option (Right to Buy)						202K	Jan 1, 2025	Common Stock	202K	$9.24	Direct	F3
holding	NEO	Stock Option (Right to Buy)						39.7K	Jan 1, 2025	Common Stock	39.7K	$19.65	Direct	F4
holding	NEO	Restricted Stock Unit						14.1K	Jan 1, 2025	Common Stock	14.1K	$0.00	Direct	F5, F6
holding	NEO	Performance Stock Unit						21.2K	Jan 1, 2025	Common Stock	21.2K	$0.00	Direct	F6, F7
holding	NEO	Stock Option (Right to Buy)						42.3K	Jan 1, 2025	Common Stock	42.3K	$16.45	Direct	F8
holding	NEO	Restricted Stock Unit						25.3K	Jan 1, 2025	Common Stock	25.3K	$0.00	Direct	F6, F9
holding	NEO	Performance Stock Unit						25.3K	Jan 1, 2025	Common Stock	25.3K	$0.00	Direct	F6, F10
holding	NEO	Stock Option (Right to Buy)						20K	Jan 1, 2025	Common Stock	20K	$13.96	Direct	F11
holding	NEO	Restricted Stock Unit						11.9K	Jan 1, 2025	Common Stock	11.9K	$0.00	Direct	F6, F12
holding	NEO	Performance Stock Unit						11.9K	Jan 1, 2025	Common Stock	11.9K	$0.00	Direct	F6, F13

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares surrendered to NeoGenomics, Inc. for retirement to satisfy the tax obligations in connection with the January 1, 2025 vesting of restricted stock.
F2	This balance includes 1,589 shares that were acquired pursuant to NeoGenomics' Employee Stock Purchase Plan (ESPP) since the date of the reporting person's last filing. The shares were acquired in transactions exempt from Section 16b-3.
F3	On January 1, 2023, Ms. Harris was granted 201,613 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F4	On May 11, 2023, Ms. Harris was granted 39,683 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F5	On May 11, 2023, Ms. Harris was granted 21,204 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F6	Once vested, the shares of common stock are not subject to expiration.
F7	On May 11, 2023, Ms. Harris was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 31,806. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.
F8	On February 23, 2024, Ms. Harris was granted 42,344 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F9	On February 23, 2024, Ms. Harris was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F10	On February 23, 2024, Ms. Harris was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
F11	On May 2, 2024, Ms. Harris was granted 19,984 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F12	On May 2, 2024, Ms. Harris was granted 11,939 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F13	On May 2, 2024, Ms. Harris was granted 11,939 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 17,909. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.